SPONSOR

Washington University School of Medicine

Total Trials

Recruiting

Phases

Phase 1, Phase 2, EARLY_Phase 1, Phase 4, Phase 1, Phase 2, Phase 2, Phase 3

Conditions studied: Critical Illness End of Life Quality of Life Pelvic Pain Endometriosis Migraine Whole Genome Sequencing Acute Myeloid Leukemia Myelodysplastic Syndromes Dietary Sources of Sodium

Washington University School of Medicine is a clinical research sponsor with 34 registered studies on ClinicalTrials.gov, of which 34 are actively recruiting participants. Research covers conditions including Critical Illness, End of Life, Quality of Life, Pelvic Pain.

The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Washington University School of Medicine

How many clinical trials has Washington University School of Medicine sponsored?

ClinicalMetric currently tracks 34 clinical trials sponsored by Washington University School of Medicine, of which 34 are actively recruiting participants. These trials cover conditions including Critical Illness, End of Life, Quality of Life. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Washington University School of Medicine research focus on?

Washington University School of Medicine clinical trials span Critical Illness, End of Life, Quality of Life, Pelvic Pain, Endometriosis, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Washington University School of Medicine clinical trial?

To participate in a Washington University School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Washington University School of Medicine trials with current recruitment status updated daily.

Washington University School of Medicine

Frequently Asked Questions — Washington University School of Medicine

Clinical Trials by Washington University School of Medicine

Embedded Palliative Care in the MICU

Endometriosis Pain

Endometriosis and Migraine

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

Smoldering Inflammation in MS

Advancing Biopsychosocial Care Training Initiative

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1

Substance Use in Pregnant People - Optimizing Retention in Treatment

Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

PET Imaging of MMP Activation in AAA: Clinical Component

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

Study to Understand Novel Biomarkers in Researching Dementia

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Wheelchair User Physical Activity Training Intervention to Enhance Cardiometabolic Health

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Migraine in Adolescents

Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1